3 ms·
None of that really addresses the public health policy question of what to do about drugs/compounds that are identified as strong candidate treatments.
by maxerickson 7y ago
None of that really addresses the public health policy question of what to do about drugs/compounds that are identified as strong candidate treatments.
- refurb 7y agoI don’t think this alternative is a “strong candidate”. And at any rate, if Gilead choses not to develop it, then someone else can try to license it if they want to gamble on it being a good product.